DR. MARK STEVEN KRAMER, M.D., PH.D.
Psychiatric in Dresher, PA
License number
Pennsylvania MD019924E
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Pennsylvania MD019924E
Category
Neurology
Type
Behavioral Neurology & Neuropsychiatry
License number
Pennsylvania MD019924E
Category
Psychiatric
Type
Psychiatry
License number
Pennsylvania MD019924E
Category
Psychiatric
Type
Geriatric Psychiatry
Address
Address
1412 Lantern Cir Office #200, Dresher, PA 19025
Phone
(215) 498-1820
Personal information
See more information about MARK STEVEN KRAMER at radaris.comName
Address
Phone
4964 Persimmon Dr, Reading, PA 19606
5020 Country Top Trl, Bethlehem, PA 18020
4701 Pennell Rd APT J8, Aston, PA 19014
520 Main St, Blandon, PA 19510
Professional information
Dr. Mark S Kramer, Dresher PA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
1412 Lantern Cir SUITE 200, Dresher 19025
(215) 498-1820 (Phone)
(215) 498-1820 (Phone)
Certifications:
Psychiatry, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Temple University
Graduated: 1976
Eppi
Temple U
Temple University
Graduated: 1976
Eppi
Temple U
Method For Treating Or Preventing Psychosomatic And Psychoimmunologic Disorders
US Patent:
6573261, Jun 3, 2003
Filed:
May 15, 2001
Appl. No.:
09/855408
Inventors:
Nadia Rupniak - Bishops Stortford, GB
Mark S. Kramer - Dresher PA
Mark S. Kramer - Dresher PA
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
A61K 31535
US Classification:
5142315, 5142355, 5142358, 5142362, 5142368
Abstract:
This invention relates to the use of a tachykinin receptor antagonist for treating a psychosomatic or a psychoimmunological disorder in a patient.
Method For Treating Or Preventing Psychosomatic And Psychoimmunologic Disorders
US Patent:
6232311, May 15, 2001
Filed:
Aug 10, 1999
Appl. No.:
9/371394
Inventors:
Nadia Rupniak - Bishops Stortford, GB
Mark S. Kramer - Dresher PA
Mark S. Kramer - Dresher PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31535
US Classification:
5142362
Abstract:
A tachykinin receptor antagonist is useful for treating or preventing a psychosomatic disorder in a patient.
Method For Treating Attention Deficit Disorder
US Patent:
6242446, Jun 5, 2001
Filed:
May 31, 2000
Appl. No.:
9/583611
Inventors:
David L. Glatt - Doylestown PA
Mark S. Kramer - Dresher PA
Nadia Rupniak - Bishops Stortford, GB
Mark S. Kramer - Dresher PA
Nadia Rupniak - Bishops Stortford, GB
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 315377, A61K 31445, A61K 314468, A61K 314035
US Classification:
5142362
Abstract:
Tachykinin receptor antagonists that are useful for treating or preventing attention deficit disorder, optionally associated with hyperactivity in a patient, are desclosed.
Method For Treating Attention Deficit Disorder
US Patent:
6121261, Sep 19, 2000
Filed:
Nov 19, 1998
Appl. No.:
9/196487
Inventors:
David L. Glatt - Doylestown PA
Mark S. Kramer - Dresher PA
Nadia Rupniak - Bishops Stortford, GB
Mark S. Kramer - Dresher PA
Nadia Rupniak - Bishops Stortford, GB
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31535, A61K 3154
US Classification:
5142362
Abstract:
A tachykinin receptor antagonist is useful for treating or preventing attention deficit disorder, optionally associated with hyperactivity, in a patient.
Method For Treating Or Preventing Psychoimmunological Disorders
US Patent:
5972938, Oct 26, 1999
Filed:
Nov 25, 1998
Appl. No.:
9/199370
Inventors:
Nadia Rupniak - Bishops Stortford, GB
Mark S. Kramer - Dresher PA
Mark S. Kramer - Dresher PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31535
US Classification:
5142362
Abstract:
A tachykinin receptor antagonist is useful for treating or preventing a psychoimmunological disorder in a patient.